Citadel Advisors’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
469,715
-28,913
-6% -$52.6K ﹤0.01% 6712
2025
Q4
$693K Buy
498,628
+164,540
+49% +$331K ﹤0.01% 8231
2025
Q3
$752K Buy
334,088
+77,443
+30% +$206K ﹤0.01% 8174
2025
Q2
$636K Buy
+256,645
New +$434K ﹤0.01% 8057
2025
Q1
Sell
-121,684
Closed -$260K 14409
2024
Q4
$327K Buy
121,684
+66,006
+119% +$207K ﹤0.01% 9475
2024
Q3
$128K Sell
55,678
-88,161
-61% -$247K ﹤0.01% 10786
2024
Q2
$433K Buy
143,839
+35,669
+33% +$136K ﹤0.01% 8341
2024
Q1
$648K Buy
108,170
+9,040
+9% +$34.3K ﹤0.01% 7811
2023
Q4
$519K Sell
99,130
-129,906
-57% -$614K ﹤0.01% 8020
2023
Q3
$950K Buy
229,036
+131,427
+135% +$804K ﹤0.01% 6658
2023
Q2
$715K Buy
97,609
+36,014
+58% +$137K ﹤0.01% 7147
2023
Q1
$143K Sell
61,595
-82,245
-57% -$306K ﹤0.01% 10721
2022
Q4
$570K Buy
143,840
+132,523
+1,171% +$753K ﹤0.01% 7976
2022
Q3
$69K Sell
11,317
-20,975
-65% -$160K ﹤0.01% 11397
2022
Q2
$159K Buy
32,292
+22,136
+218% +$193K ﹤0.01% 10929
2022
Q1
$129K Sell
10,156
-59,147
-85% -$652K ﹤0.01% 12019
2021
Q4
$852K Buy
69,303
+6,417
+10% +$113K ﹤0.01% 8345
2021
Q3
$1.15M Buy
62,886
+30,359
+93% +$336K ﹤0.01% 7793
2021
Q2
$363K Sell
32,527
-206,408
-86% -$3.25M ﹤0.01% 10805
2021
Q1
$5.86M Buy
238,935
+180,468
+309% +$2.02M ﹤0.01% 3913
2020
Q4
$146K Buy
+58,467
New +$178K ﹤0.01% 9961
2020
Q3
Sell
-14,522
Closed -$11K 10026
2020
Q2
$11K Buy
+14,522
New +$10.6K ﹤0.01% 9623
2019
Q3
Sell
-50,725
Closed -$43K 9118
2019
Q2
$43K Buy
50,725
+22,803
+82% +$21.9K ﹤0.01% 8767
2019
Q1
$23K Buy
27,922
+9,417
+51% +$8.68K ﹤0.01% 9039
2018
Q4
$11K Sell
18,505
-3,682
-17% -$3.2K ﹤0.01% 8907
2018
Q3
$23K Buy
22,187
+7,896
+55% +$10.3K ﹤0.01% 8988
2018
Q2
$22K Buy
+14,291
New +$23.3K ﹤0.01% 8623
2017
Q3
Sell
-14,949
Closed -$20K 7488
2017
Q2
$20K Buy
+14,949
New +$19.9K ﹤0.01% 7288
2016
Q4
Sell
-11,264
Closed -$13K 7202
2016
Q3
$13K Buy
+11,264
New +$18.9K ﹤0.01% 7125

Other funds holding AMTX

Citadel Advisors's AMTX Position: Q1 2026 in Review

Citadel Advisors reduced its Aemetis (AMTX) stake by 5.8% in Q1 2026, selling an estimated $52.6K and leaving 469,715 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #6712.

Citadel Advisors first reported a position in AMTX in Q3 2016 and has held it in 29 quarters since. The position peaked at $5.86M in Q1 2021. 78 funds tracked by Wall St. Rank hold AMTX as of Q1 2026.

  • Citadel Advisors held 469,715 shares of Aemetis worth $1.5M as of Q1 2026.
  • Citadel Advisors sold 28,913 Aemetis shares in Q1 2026, an estimated $52.6K.
  • Aemetis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6712 holding.
  • Citadel Advisors first reported a position in Aemetis in Q3 2016 and has held it in 29 quarters since.
  • Citadel Advisors's Aemetis position peaked at $5.86M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Aemetis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.